Eli Lilly & Co. (LLY) stock analysis and AI prediction
The company facts of Eli Lilly & Co., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
- Sector
- Healthcare
- Exchange
- NYSE
- Market value
- $1.2 trillion
- Size
- Mega cap
- Employees
- 50,000
- Headquarters
- INDIANAPOLIS, IN
- Listed since
- July 9, 1970
- Website
- lilly.com
More Healthcare stocks
Other mega cap stocks
Keep going
LLY questions
What is the AI prediction for LLY stock?
Each market day our model rates Eli Lilly & Co. (LLY) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the LLY prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for LLY?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see LLY options?
The LLY options page opens its calls and puts, with price, volume, implied volatility and the Greeks.